Evidencia científica sobre el uso de ivermectina para Covid-19

Publicado el 23 Enero 2021

Análisis breve de la evidencia y recomendaciones sobre el uso de Ivermectina en COVID-19 - Instituto Mexicano del Seguro Social (IMSS)

Descargar artículo


Ivermectin reduces the risk ofdeath from COVID-19 –a rapid review and meta-analysis in support oftherecommendationofthe Front Line COVID-19 Critical Care Alliance.

Descargar artículo


Ivermectin is Now a Treatment Option for Health Care Providers!

Leer artículo


Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection

Leer artículo


The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leer artículo


El fármaco Ivermectina aprobado por la FDA inhibe la replicación de SARS- CoV-2 in Vitro.

Descargar artículo


Preliminary meta-analysis of randomized trials of ivermectin to treat SARS- CoV-2 infection - International Ivermectin Project Team

Descargar artículo


Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

Leer artículo


Role of ivermectin in the prevention of COVID-19 infectionamong healthcare workers in India: A matched case-controlstudy

Descargar artículo


White paper on Ivermectin as a potential therapy for COVID-19

Leer artículo


Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study

Leer artículo


Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19

Descargar artículo


In vivo use of ivermectin (IVR) for treatment for corona virus infected patients (COVID-19): a randomized controlled trial

Leer artículo


Use of Ivermectin as a prophylactic option in asymptomatic family close contacts for patients with COVID-19

Leer artículo


A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients

Descargar artículo


Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial

Leer artículo


Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Leer artículo


Efficacy of Ivermectin in COVID-19

Leer artículo


Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Leer artículo


Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double blind dose response study in Lagos

Leer artículo


Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation

Descargar artículo


Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

Descargar artículo


Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

Descargar artículo


Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2

Leer artículo


Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study

Leer artículo


Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Descargar artículo


The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

Leer artículo


A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin

Leer artículo